Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Viral vector and nucleic acid vaccines against COVID-19: A narrative review
Saeed Khoshnood, Roya Ghanavati, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25

Showing 25 citing articles:

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Xiaodi Wu, Ke Xu, Ping Zhan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 14
A review on Zika vaccine development
Zhe‐Yu Peng, Yang Song, Hong‐Zheng Lu, et al.
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 8
Advanced nanoscale delivery systems for mRNA-based vaccines
Maha W. Mobasher, Rais A. Ansari, Ana M. Castejón, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 3, pp. 130558-130558
Closed Access | Times Cited: 7
Influence of Microbiota on Vaccine Effectiveness: “Is the Microbiota the Key to Vaccine-induced Responses?”
So‐Hee Hong
The Journal of Microbiology (2023) Vol. 61, Iss. 5, pp. 483-494
Open Access | Times Cited: 14
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris
Sibel Kalyoncu, Semiramis Yılmaz, Ayça Zeybek Kuyucu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Anirudha Chattopadhyay, A. Abdul Kader Jailani, Bikash Mandal
Vaccines (2023) Vol. 11, Iss. 8, pp. 1347-1347
Open Access | Times Cited: 12
Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis
Albert J. Czaja
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 7, pp. 2824-2842
Open Access | Times Cited: 10
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
Shenyu Wang, Wenqing Liu, Yuqing Li, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 704-713
Open Access | Times Cited: 10
Immunogenicity and safety of a self-assembling ZIKV nanoparticle vaccine in mice
Ting Liu, Meng Li, Yang Tian, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124320-124320
Closed Access | Times Cited: 2
The Significance of Digitalisation and Artificial Intelligence in The Healthcare Sector: A Review
Maad M. Mijwil, Alaa K. Faieq, Abdel‐Hameed Al‐Mistarehi
Asian Journal of Pharmacy Nursing and Medical Sciences (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 13
Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia
Karan Thakkar, Júlia Spinardi, Jingyan Yang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations
Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul, et al.
Life Sciences (2024), pp. 122861-122861
Open Access | Times Cited: 1
The Covid-19 pandemic and the analysis of the current epidemiological situation in Uzbekistan and the neighboring countries of Central Asia, as well as the world (analytical review)
Dilfuza A Alieva, Jasur Rizaev, A. A. Sadikov
Biometrics & Biostatistics International Journal (2024) Vol. 13, Iss. 2, pp. 65-70
Open Access | Times Cited: 1
Acceptance‐Hesitancy of COVID‐19 Vaccination and Factors Affecting It in Adults: Systematic Review Study
Atieh Darbandi, Maryam Koupaei, Parisa Kiani, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 1
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 1
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Co‐delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1‐dominant humoral and cellular immunity against SARS‐CoV‐2
Hung‐Chun Liao, Min‐Syuan Huang, Fang‐Feng Chiu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 2
Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection
Elias A. Said, Afnan Al-Rubkhi, Sanjay Jaju, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 104-104
Open Access
Leveraging Innovative Vaccines in Conquering Emerging Infectious Diseases
A. K. M. Shafiul Kadir, Pranav Kumar Prabhakar, Jannatul Ferdause, et al.
Advances in bioinformatics and biomedical engineering book series (2024), pp. 81-116
Closed Access
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial
Xu Han, Mingwei Wei, Xiuyu Zheng, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 683-683
Open Access
State of the Art of Immunoinformatics
Eduarda Guimarães Sousa, Lucas Gabriel Rodrigues Gomes, Fernanda Diniz Prates, et al.
Advances in bioinformatics and biomedical engineering book series (2024), pp. 69-106
Closed Access
COVID-19 story: Entry and immune response
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
Vacunas (2024)
Closed Access
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study
Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, et al.
Vacunas (2022) Vol. 24, Iss. 2, pp. 141-149
Open Access | Times Cited: 2
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study
Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, et al.
Vacunas (English Edition) (2023) Vol. 24, Iss. 2, pp. 141-149
Open Access
Advanced Formulation Approaches for Emerging Therapeutic Technologies
Nour Allahham, Ines Colic, Melissa Rayner, et al.
Handbook of experimental pharmacology (2023), pp. 343-365
Closed Access
Page 1

Scroll to top